Company intelligence / Profile preview

Scinogy

Melbourne, Victoria, Australia

Ownership: Private
Development stage: Other

Overview

Scinogy develops and provides closed, automated, and modular cell processing and counter-flow centrifugation systems used to manufacture cell and gene therapies; its technology (commercialized by Thermo Fisher as the Gibco CTS Rotea system) is used across research through clinical and commercial manufacturing but Scinogy itself does not run therapeutic clinical trials.[1][2][3][6][8]

Modalities: DeviceCell therapyGene therapy
Industry: Therapeutic Medical Devices

Partnerships

Thermo Fisher Scientific[2][6][8]Planet Innovation[2][7]Hudson Institute of Medical Research[3]Monash Health Translation Precinct (co-location / collaboration)[3]

Beyond the preview

Go deeper on Scinogy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scinogy.

Explore the full profile